OBD

OXFORD BIODYNAMICS PLC ORD GBP0.01

TitleTime
Business update and notice of interim resultsThu 21/05/20 | 07:00
PDMR DealingFri 15/05/20 | 12:47
PDMR DealingThu 14/05/20 | 12:39
Change of Registered OfficeFri 01/05/20 | 07:00
PDMR DealingWed 22/04/20 | 13:12
PDMR DealingMon 20/04/20 | 11:10
PDMR DealingFri 17/04/20 | 10:47
Price Monitoring ExtensionThu 16/04/20 | 16:35
PDMR DealingWed 15/04/20 | 15:10
PDMR DealingTue 14/04/20 | 11:42
PDMR DealingWed 08/04/20 | 16:34
PDMR Dealing - ReplacementThu 02/04/20 | 11:08
PDMR Dealing / Grant of Share OptionsTue 31/03/20 | 07:00
PDMR ShareholdingFri 20/03/20 | 15:02
Results of Annual General MeetingFri 20/03/20 | 13:37
Director DealingFri 20/03/20 | 07:30
Director DealingThu 19/03/20 | 07:00
PDMR DealingWed 18/03/20 | 07:00
Board restructure to support future growthMon 16/03/20 | 07:00
PDMR DealingMon 02/03/20 | 17:04
Correction - PDMR DealingMon 02/03/20 | 17:03
Correction - PDMR DealingMon 02/03/20 | 17:02
PDMR DealingFri 28/02/20 | 14:08
PDMR DealingWed 26/02/20 | 11:49
Second Price Monitoring ExtnThu 13/02/20 | 16:41
Price Monitoring ExtensionThu 13/02/20 | 16:35
Publication of Annual Report and Notice of AGMThu 23/01/20 | 07:00
EpiSwitch used in diagnosis of canine lymphomaWed 15/01/20 | 14:15
OBD enters into master service agreementFri 20/12/19 | 07:00
PDMR ShareholdingWed 11/12/19 | 11:00
Prelim Results for year ended 30 September 2019Tue 10/12/19 | 07:00
Notice of ResultsTue 19/11/19 | 07:00
PDMR DealingThu 12/09/19 | 12:43
PDMR DealingTue 10/09/19 | 10:26
PDMR DealingMon 09/09/19 | 12:48
PDMR DealingFri 06/09/19 | 10:59
PDMR DealingTue 03/09/19 | 09:47
PDMR DealingMon 02/09/19 | 11:18
PDMR DealingThu 29/08/19 | 15:30
PDMR DealingWed 28/08/19 | 10:11
PDMR DealingThu 15/08/19 | 10:59
PDMR DealingWed 14/08/19 | 13:15
PDMR DealingMon 05/08/19 | 11:19
PDMR DealingThu 01/08/19 | 09:51
PDMR ShareholdingFri 26/07/19 | 11:57
Director/PDMR ShareholdingTue 09/07/19 | 07:00
PDMR Dealing / Grant of Share OptionsWed 12/06/19 | 07:00
Director/PDMR ShareholdingThu 06/06/19 | 15:14
Board TransitionFri 31/05/19 | 07:00
Interim Results for 6 months ended 31 March 2019Tue 28/05/19 | 07:00
Notice of Interim ResultsMon 29/04/19 | 07:50
Board AppointmentsFri 05/04/19 | 09:30
Results of Annual General MeetingThu 14/03/19 | 14:13
Director/PDMR ShareholdingFri 15/02/19 | 10:01
Publication of Annual Report and Notice of AGMFri 25/01/19 | 07:00
Board TransitionFri 11/01/19 | 07:00
Final ResultsTue 11/12/18 | 07:00
Total Voting RightsMon 03/12/18 | 10:10
Notice of results for year ended 30 Sept 2018Fri 23/11/18 | 07:00
Issue of EquityTue 06/11/18 | 07:00
Total Voting RightsThu 01/11/18 | 17:17
Issue of EquityTue 02/10/18 | 07:00
Issue of EquityWed 26/09/18 | 07:00
Total Voting RightsTue 04/09/18 | 10:03
Holding(s) in CompanyThu 30/08/18 | 14:57
Holding(s) in CompanyWed 29/08/18 | 16:52
Holding(s) in CompanyWed 29/08/18 | 16:48
Holding(s) in CompanyWed 29/08/18 | 16:47
Holding(s) in CompanyWed 29/08/18 | 16:46
Holding(s) in CompanyWed 29/08/18 | 16:43
Chinese Investment Group Takes Stake in OBDWed 22/08/18 | 07:00
Grant of Canadian patent for EpiSwitch platformThu 19/07/18 | 07:00
Total Voting RightsMon 02/07/18 | 17:50
Issue of EquityTue 19/06/18 | 07:00
Interim Results for the Period Ended 31 March 2018Tue 22/05/18 | 07:00
Total Voting RightsTue 01/05/18 | 07:00
Notice of Interim ResultsTue 17/04/18 | 07:00
Issue of EquityThu 05/04/18 | 11:41
PDMR Dealing/Grant of Share OptionsMon 19/03/18 | 07:00
Results of Annual General MeetingThu 15/03/18 | 14:10
Publication of Annual Report and Notice of AGMThu 15/02/18 | 07:00
Grant of Indian patent for EpiSwitch platformWed 14/02/18 | 13:11
Shore Capital appointed as NOMAD and Sole BrokerTue 30/01/18 | 07:01
Final Results for the Year Ended 30 September 2017Tue 30/01/18 | 07:00
Notice of ResultsTue 16/01/18 | 07:00
Holding(s) in CompanyFri 05/01/18 | 15:05
Signs 2nd agreement with US biopharma companyWed 03/01/18 | 07:00
Total Voting RightsTue 02/01/18 | 15:00
Director/PDMR ShareholdingThu 21/12/17 | 07:00
Exercise period extension existing Share OptionsWed 13/12/17 | 07:01
EXERCISE OF WARRANTS AND DIRECTOR DEALINGTue 05/12/17 | 07:00
Notification of major holdingsMon 06/11/17 | 12:29
Announces grant of US patent for EpiSwitchTTue 03/10/17 | 07:00
Successful in diagnosing and staging breast cancerThu 28/09/17 | 07:00
Directorate UpdateFri 15/09/17 | 07:00
Appointment of Paul Stockdale as CFOFri 30/06/17 | 07:00